BOTALYS
PrivateLast Round
Series B
Oct 4, 2022
Total Funding Raised
$11.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BOTALYS is a biotechnology company that produces potent and pure botanical ingredients for the nutraceutical and cosmetic industries using a proprietary vertical farming technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BOTALYS Comparables
Compare BOTALYS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ljusgårda AB | 83% | |
| Plant Advanced Technologies PAT | 82% | |
| Interstellar Lab | 79% | |
BOTALYS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 4, 2022 | ||||
| Grant | May 31, 2021 | ||||
| Grant | Mar 1, 2019 | ||||
| VC Round | Jan 9, 2019 |
Key People
Founding team and executive leadership
BOTALYS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Société Régionale d'Investissement de Wallonie | Series B |
| Air Liquide Venture Capital | Series B |
| VIVES Partners | VC Round |
| Wapinvest | Series B, Seed |
| European Union | Grant |
| The Yield Lab | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 163% MoM.
- Jan 22, 2026
Added L’Oréal Group, a beauty & personal care company, as a customer.
BOTALYS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BOTALYS's valuation, stock price, and market status.